Showing results (21-30 of 406) with videos related to
Sort By:
Pageof 41
Cancers|March 29, 2023
Post-CDK 4/6 Inhibitor Therapy: Current Agents and Novel TargetsNadia Ashai, Sandra M SwainCancer Investigation|June 13, 2014
Pertuzumab for the treatment of breast cancerFilipa Lynce, Sandra M SwainClinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 13, 2009
Phosphoinositide 3-kinase mutations in breast cancer: a "good" activating mutation?Serena Di Cosimo, José BaselgaNature Reviews. Clinical Oncology|February 4, 2010
Management of breast cancer with targeted agents: importance of heterogeneity. [corrected]Serena Di Cosimo, José BaselgaThe Journal of Clinical Investigation|October 4, 2011
Targeted therapies for breast cancerMichaela J Higgins, José BaselgaCancer Discovery|September 13, 2012
Whole-genome sequencing and cancer therapy: is too much ever enough?Levi A Garraway, José BaselgaNature Reviews. Clinical Oncology|February 1, 2011
Breast cancer in 2010: Novel targets and therapies for a personalized approachMichaela J Higgins, José BaselgaJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 9, 2005
Critical update and emerging trends in epidermal growth factor receptor targeting in cancerJosé Baselga, Carlos L ArteagaEuropean Journal of Cancer (Oxford, England : 1990)|November 18, 2008
Targeted therapies in breast cancer: where are we now?Serena Di Cosimo, José BaselgaPageof 41